Skip to main content
OpenTrials

Clinical trial condition

Nevi and Melanomas

Explore clinical trials studying Nevi and Melanomas. Study availability and eligibility vary by location and protocol.

2,361 public trials 406 recruiting studies
Refine in advanced search Browse all conditions

Nevi and Melanomas trial results

Active, Not Recruiting

SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

NCT03161431

Conditions
Melanoma, Melanoma Stage III, Melanoma Stage IV, +11 more
Locations
  • University of Miami Miami, Florida, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

SCIB1 and iSCIB1+ in Melanoma Patients Receiving Nivolumab With Ipilimumab or SCIB1 With Pembrolizumab (The SCOPE Study)

NCT04079166

Conditions
Malignant Melanoma, Melanoma, Melanoma (Skin), +13 more
Locations
  • Cambridge University Hospitals NHS Foundation Trust Cambridge, United Kingdom
  • Velindre University NHS Trust Cardiff, United Kingdom
  • The Leeds Teaching Hospitals NHS Trust Leeds, United Kingdom
  • Guy's & St Thomas' NHS Foundation Trust London, United Kingdom
View all 15 locations
View Trial Details
Active, Not Recruiting

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

NCT04198766

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +56 more
Locations
  • City of Hope Duarte, California, United States
  • Los Angeles Cancer Network Glendale, California, United States
  • California Research Institute Los Angeles, California, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate INCB099280 in Participants With Select Solid Tumors Who Are Immune Checkpoint Inhibitor Naive

NCT05879822

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +36 more
Locations
  • Fundacao Pio Xii Hospital de Cancer de Barretos Barretos, Brazil
  • Cionc-Centro Integrado de Oncologia de Curitiba Curitiba, Brazil
  • Hospital Erasto Gaertner - Liga Paranaense de Combate Ao Câncer Curitiba, Brazil
  • Oncosite - Centro de Pesquisa Clinica E Oncologia Ijuí, Brazil
View all 54 locations
View Trial Details
Active, Not Recruiting

Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases

NCT02374242

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +20 more
Locations
  • Melanoma Institute Australia Wollstonecraft, New South Wales, Australia
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia
View Trial Details
Active, Not Recruiting

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

NCT03897881

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • California Pacific Medical Center Research Institute -CPMCRI San Francisco, California, United States
  • Angeles Clinic and Research Institute Santa Monica, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 23 locations
View Trial Details

Related conditions